VIVA
VIVA
November 08, 2018
2 min watch
Save

VIDEO: A 'new wave of innovation' for CLI

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

LAS VEGAS — In this video exclusive, Jihad A. Mustapha, MD, FACC, FSCAI, highlights results of the anticipated Lutonix BTK study showing safety and efficacy of a drug-coated balloon in below-the-knee lesions.

The randomized trial, presented by Mustapha at VIVA 18, compared outcomes with the Lutonix 014 DCB (BD) and percutaneous transluminal angioplasty in patients with narrowed or obstructed arteries below the knee.

“I’m hoping to see a real iteration and a whole new wave of innovation and hope … for new drug-coated balloon technologies in research and development … for critical limb ischemia, because critical limb ischemia isn’t going anywhere so we’ve got to find multiple methods to treat it,” Mustapha, CLI specialist at Advanced Cardiac and Vascular Amputation Prevention Centers in Grand Rapids, Michigan, told Cardiology Today’s Intervention.

Watch the video for more.